Stem Cell Firm Cryo-Save Group Forms Genomics, Proteomics Business Unit | GenomeWeb

NEW YORK (GenomeWeb) – Stem cell storage company Cryo-Save Group today announced the formation of a business unit focused on predictive medicine using genomics and proteomics technologies.

The creation of the unit, called Genoma, is part of a wide-ranging reorganization of Cryo-Save's operations that also include the formation two other business units focused on cord blood and tissue cyro-preservation and translational regenerative medicine R&D.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.